Skip to content

Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude

Protocol for the Evaluation of Dario™ Blood Glucose Monitor (BGMS) Performance at Elevated Altitude

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02352298
Enrollment
52
Registered
2015-02-02
Start date
2015-02-28
Completion date
2015-02-28
Last updated
2017-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study is to assess the performance of the Dario Blood Glucose Monitor (BGMS), at elevated altitudes, by obtaining whole blood fingerstick samples from individuals and analyzing the blood on the Dario Blood Glucose Monitor (BGMS) and comparing the readings to readings obtained from the YSI 2300 STAT Plus glucose analyzer.

Detailed description

The study will be performed with 50 fresh capillary blood samples, collected by fingerstick using Dario single use lancet. Additional fingerstick with dedicated disposable lancets will be used to collect sufficient capillary fresh blood to be analyzed by the YSI 2300 STAT Plus analyzer. Additional fingersticks may be necessary if volume of blood from first fingerstick is insufficient.

Interventions

Fingerstick to obtain blood sample for analysis with the Dario BGMS

DEVICEYSI Analyzer

Fingerstick to obtain blood sample for analysis with YSI

Sponsors

LabStyle Innovations Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age of subject is 18 years or older * Able to speak and read English

Exclusion criteria

* Pregnant * Has any condition that the principal investigator believes may interfere in the subject's participation in the trial.

Design outcomes

Primary

MeasureTime frameDescription
Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)6 secondsAccuracy of Dario Blood Glucose Monitoring System when compared to Yellow Springs Instrument 2300 reference method at 10,152 feet above sea level. Acceptance criteria set per (International Organization for Standardization) ISO 15197:2003. Greater than or equal to 95% of the Dario results shall fall within plus or minus 15 mg/dL of the reference method value (for glucose concentrations \<75 mg/dL). For glucose concentrations greater than or equal to 75 mg/dL, the Dario results shall fall within plus or minus 20% of the reference method value.

Countries

United States

Participant flow

Pre-assignment details

52 subjects - two blood glucose assessment types each (Dario vs YSI). Totaling 104 samples of blood for with 312 data points generated across 6 Dario meters and 1 YSI assessment per subject (52 total YSI assessments).

Participants by arm

ArmCount
Dario and Yellow Springs Instrument
Blood obtained via fingerstick and blood glucose level is tested on the Dario Blood Glucose Monitoring System and the Yellow Springs Instrument for comparison.
52
Total52

Baseline characteristics

CharacteristicDario and Yellow Springs Instrument
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
50 Participants
Age, Continuous41.44 years
Region of Enrollment
United States
52 participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 520 / 52
serious
Total, serious adverse events
0 / 520 / 52

Outcome results

Primary

Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)

Accuracy of Dario Blood Glucose Monitoring System when compared to Yellow Springs Instrument 2300 reference method at 10,152 feet above sea level. Acceptance criteria set per (International Organization for Standardization) ISO 15197:2003. Greater than or equal to 95% of the Dario results shall fall within plus or minus 15 mg/dL of the reference method value (for glucose concentrations \<75 mg/dL). For glucose concentrations greater than or equal to 75 mg/dL, the Dario results shall fall within plus or minus 20% of the reference method value.

Time frame: 6 seconds

ArmMeasureGroupValue (NUMBER)
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 75 mg/dl Within ±5mg/dL28.6 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 75 mg/dl Within ±10mg/dL71.4 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 75 mg/dl Within ±15mg/dL100 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>= 75 mg/dl Within ±5%32.5 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>= 75 mg/dl Within ±10%60.1 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>=75 mg/dl Within ±15%87.6 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>=75 mg/dl Within ±20%99.2 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 100 mg/dl Within ±5mg/dL28.8 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 100 mg/dl Within ±10mg/dL61.4 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)< 100 mg/dl Within ±15mg/dL97.7 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>=100 mg/dl Within ±5%35.7 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>=100 mg/dl Within ±10%65.5 percentage of participants
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)>=100 mg/dl Within ±15%95.2 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026